日本放射化学会第66回討論会(2022)

Presentation information

特別セッション 核医学の礎を担う放射化学の新展開

特別セッション 2 核医学の礎である放射化学の新展開

特別セッション 2 核医学の礎である放射化学の新展開

Thu. Sep 15, 2022 10:00 AM - 11:10 AM A会場 (小柴ホール)

Chair:Hayato Ikeda(Tohoku University)

10:25 AM - 10:40 AM

[1A02] Development of pre-targeting system using low immunogenic streptavidin mutants and 211-At-labeled bis-iminobiotin

*Toshifumi Tatsumi1, Kenzo Yamatsugu1, Akira Sugiyama2, Songji Zhao3, Miho Aoki3, Ken-ichi Nishijima3, Naoyuki Ukon3, Saki Shimoyama3, Tan Chengbo3, Taiki Joho3, Noboru Oriuchi3, Kazuhiro Takahashi3, Yohei Shimizu1, Kazuki Takahashi1, Sho Aki4, Tatsuhiko Kodama4, Kohshin Washiyama3, Motomu Kanai1 (1. Grad. Sch. Pharm. Sci., The University of Tokyo., 2. Isotope Science Center, The University of Tokyo, 3. Advanced Clinical Research Center, Fukushima Medical University,, 4. Research Center for Advanced Science and Technology, The University of Tokyo)

Abstract password authentication.
Password is required to view the abstract. Please enter a password to authenticate.

Password